Showing 1–34 of 34 results
-
Research |
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study
- Laetitia Largeaud
- , Pascale Cornillet-Lefebvre
- , Jean-François Hamel
- , Pierre-Yves Dumas
- , Naïs Prade
- , Stéphanie Dufrechou
- , Julien Plenecassagnes
- , Isabelle Luquet
- , Odile Blanchet
- , Anne Banos
- , Marie C. Béné
- , Marc Bernard
- , Sarah Bertoli
- , Caroline Bonmati
- , Luc Matthieu Fornecker
- , Romain Guièze
- , Lamya Haddaoui
- , Mathilde Hunault
- , Jean Christophe Ianotto
- , Eric Jourdan
- , Mario Ojeda
- , Pierre Peterlin
- , Norbert Vey
- , Hacene Zerazhi
- , Hicheri Yosr
- , Ariane Mineur
- , Jean-Yves Cahn
- , Norbert Ifrah
- , Christian Récher
- , Arnaud Pigneux
- , Eric Delabesse
- , J.-P. Marolleau
- , A. Aleme
- , F. Orsini-Piocelle
- , N. Cadoux
- , N. Ifrah
- , M. Hunault
- , C. Marie
- , A. Al Jijakli
- , G. Lepeu
- , H. Zerazhi
- , M. Beyrne
- , A. Banos
- , S. Labarrere
- , E. Deconinck
- , M. Peria
- , A. El Yamani
- , O. Kadiri
- , B. Choufi
- , M. Brument
- , A. Pigneux
- , T. Leguay
- , P.-Y. Dumas
- , C. Berthou
- , G. Guillerm
- , G. Drugmanne
- , O. Tournilhac
- , G. Roy
- , B. Audhuy
- , S. Camara
- , D. Caillot
- , M. Grandjean
- , J.-Y. Cahn
- , C.-E. Bulabois
- , B. Fief
- , N. Vey
- , C. Ladraa
- , V. Dorvaux
- , M. Hagopian
- , N. Fegueux
- , C. Fenoll
- , V. Sabadash
- , M. Ojeda
- , C. Haby
- , F. Witz
- , C. Bonmati
- , M. Lhuire
- , J. Delaunay
- , P. Peterlin
- , L. Airiau
- , L. Mannone
- , I. Touitou
- , E. Jourdan
- , D. Umuhire
- , M. Alexis
- , O. Michel
- , F. Dreyfus
- , D. Bouscary
- , A. Cheung
- , L. Sanhes
- , F. Touhami
- , E. Ribas
- , M. Puyade
- , M.-P. Gallego-Hernanz
- , N. Hugon
- , C. Himberlin
- , L. Maggi
- , T. Lamy
- , A. Testu
- , E. Tavernier
- , S. Marchand
- , B. Lioure
- , C. Kravanja
- , L. Benboubker
- , D. Nollet
- , M. Attal
- , C. Recher
- , A. Sarry
- , A. Lhermitte
- , G. Yrica
- , D. Schwartz
- , N. Le Montagner
- , C. Fenoll
- , V. Sabadash
- , D. Nollet
- , L. Auvray
- , R. Delepine
- & A. Fayault
-
-
Research |
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
- E. González-Barca
- , A. Boumendil
- , D. Blaise
- , M. Trněný
- , T. Masszi
- , H. Finel
- , M. G. Michieli
- , J. T. Bittenbring
- , G. Gritti
- , J. A. Snowden
- , M. Bishton
- , B. Bruno
- , S. González de Villambrosia
- , A. Janikova
- , X. Leleu
- , A. Anagnostopoulos
- , X. Poiré
- , M. Crysandt
- , Z. N. Özkurt
- , E. Vandenberghe
- , M. Itälä-Remes
- , J. Y. Cahn
- , E. Jantunen
- , W. Schroyens
- , J. Maertens
- , A. Esquirol
- , P. Dreger
- , S. Montoto
- & A. Sureda
Bone Marrow Transplantation 55 , 393–399 -
Books and Arts |
-
Research | | Open
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party
- C Scheid
- , L de Wreede
- , A van Biezen
- , C Koenecke
- , G Göhring
- , L Volin
- , J Maertens
- , J Finke
- , J Passweg
- , D Beelen
- , J J Cornelissen
- , M Itälä-Remes
- , P Chevallier
- , N Russell
- , E Petersen
- , N Milpied
- , C Richard Espiga
- , A Peniket
- , J Sierra
- , G Mufti
- , C Crawley
- , J H Veelken
- , P Ljungman
- , J Y Cahn
- , E P Alessandrino
- , T de Witte
- , M Robin
- & N Kröger
Bone Marrow Transplantation 52 , 1519–1525 -
Research |
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group–an observational analysis by the Acute Leukemia Working Party of the EBMT
- J R Passweg
- , M Labopin
- , J Cornelissen
- , L Volin
- , G Socié
- , A Huynh
- , R Tabrizi
- , D Wu
- , C Craddock
- , N Schaap
- , J Kuball
- , P Chevallier
- , J Y Cahn
- , D Blaise
- , A Ghavamzadeh
- , K Bilger
- , F Ciceri
- , C Schmid
- , S Giebel
- , A Nagler
- & M Mohty
Bone Marrow Transplantation 50 , 1063–1068 -
Research |
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
- A-C Mamez
- , V Lévy
- , P Chevallier
- , D Blaise
- , S Vigouroux
- , A Xhaard
- , N Fegueux
- , N Contentin
- , Y Beguin
- , N Ifrah
- , C-E Bulabois
- , F Suarez
- , I Yakoub-Agha
- , P Turlure
- , E Deconink
- , T Lamy
- , J Y Cahn
- , A Huynh
- , S Maury
- , L M Fornecker
- , M Ouzegdouh
- , J-O Bay
- , G Guillerm
- , N Maillard
- , M Michallet
- , J-V Malfuson
- , J-H Bourhis
- , F Rialland
- , R Oumedaly
- , C Jubert
- , V Leblond
- , M Boubaya
- , M Mohty
- & S Nguyen
Bone Marrow Transplantation 51 , 358–364 -
Research |
-
Research |
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT
- S P Robinson
- , C Canals
- , J J Luang
- , H Tilly
- , C Crawley
- , J Y Cahn
- , D Pohlreich
- , S Le Gouill
- , M Gilleece
- , N Milpied
- , M Attal
- , P Biron
- , S Maury
- , A Rambaldi
- , J Maertens
- , S Capria
- , P Colombat
- , S Montoto
- & A Sureda
Bone Marrow Transplantation 48 , 1409–1414 -
Research |
-
-
-
Research |
A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
- H K Al-Ali
- , R Brand
- , A van Biezen
- , J Finke
- , M Boogaerts
- , A A Fauser
- , M Egeler
- , J-Y Cahn
- , R Arnold
- , H Biersack
- , D Niederwieser
- & T de Witte
Leukemia 21 , 1945–1951 -
Research |
-
Research |
-
Research |
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)
- E Deconinck
- , J-Y Cahn
- , N Milpied
- , J-P Jouet
- , J-P Vernant
- , H Esperou
- , B Lioure
- , P Bordigoni
- , V Leblond
- , X Troussard
- , D Caillot
- , J-M Cordonnier
- & P Hervé
Bone Marrow Transplantation 20 , 731–735 -
Research |
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research
- M R Bishop
- , B R Logan
- , S Gandham
- , B J Bolwell
- , J-Y Cahn
- , H M Lazarus
- , M R Litzow
- , D I Marks
- , P H Wiernik
- , P L McCarthy
- , J A Russell
- , C B Miller
- , J Sierra
- , G Milone
- , A Keating
- , F R Loberiza Jr
- , S Giralt
- , M M Horowitz
- & D J Weisdorf
Bone Marrow Transplantation 41 , 635–642 -
Research |
Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)
- M Mohty
- , M Attal
- , G Marit
- , C E Bulabois
- , F Garban
- , N Gratecos
- , B Rio
- , J P Vernant
- , J J Sotto
- , J Y Cahn
- , D Blaise
- , J P Jouet
- , T Facon
- & I Yakoub-Agha
Bone Marrow Transplantation 35 , 165–169 -
Research |
-
Research |
-
Research |
-
Research |
-
Research |
-
Research |
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire
- M Mohty
- , M Labopin
- , M L Balère
- , G Socié
- , N Milpied
- , R Tabrizi
- , N Ifrah
- , Y Hicheri
- , N Dhedin
- , M Michallet
- , A Buzyn
- , J-Y Cahn
- , J-H Bourhis
- , D Blaise
- , C Raffoux
- , H Espérou
- & I Yakoub-Agha
Leukemia 24 , 1867–1874 -
-
-
-
Research |
-
-
Research |
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
- V Bachanova
- , D I Marks
- , M-J Zhang
- , H Wang
- , M de Lima
- , M D Aljurf
- , M Arellano
- , A S Artz
- , U Bacher
- , J-Y Cahn
- , Y-B Chen
- , E A Copelan
- , W R Drobyski
- , R P Gale
- , J P Greer
- , V Gupta
- , G A Hale
- , P Kebriaei
- , H M Lazarus
- , I D Lewis
- , V A Lewis
- , J L Liesveld
- , M R Litzow
- , A W Loren
- , A M Miller
- , M Norkin
- , B Oran
- , J Pidala
- , J M Rowe
- , B N Savani
- , W Saber
- , R Vij
- , E K Waller
- , P H Wiernik
- & D J Weisdorf
-
Research |
-
Research |
A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society
- H Espérou
- , J-M Boiron
- , J-M Cayuela
- , O Blanchet
- , M Kuentz
- , J-P Jouet
- , N Milpied
- , J-Y Cahn
- , C Faucher
- , J-H Bourhis
- , M Michallet
- , M-L Tanguy
- , J-P Vernant
- , J Gabert
- , P Bordigoni
- , N Ifrah
- , A Baruchel
- & H Dombret
Bone Marrow Transplantation 31 , 909–918 -
Research |
-
Research |
